Leif Klint

472 total citations
5 papers, 32 citations indexed

About

Leif Klint is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Leif Klint has authored 5 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Leif Klint's work include HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Breast Cancer Treatment Studies (2 papers). Leif Klint is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Breast Cancer Treatment Studies (2 papers). Leif Klint collaborates with scholars based in Sweden, Denmark and Finland. Leif Klint's co-authors include Ernesto Sparrelid, Christina Biörserud, Jon Erik Grønbech, Per Pfeiffer, Svein Dueland, Kristoffer Lassen, Bobby Tingstedt, Johan Haux, Kjetil Søreide and Knut Jørgen Labori and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Breast Cancer Research and Treatment.

In The Last Decade

Leif Klint

4 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leif Klint Sweden	2	30	16	14	9	8	5	32
Alexander Reichart Germany	3	30 1.0×	14 0.9×	16 1.1×	13 1.4×	11 1.4×	11	36
Imane H. El Dika United States	4	40 1.3×	6 0.4×	13 0.9×	7 0.8×	16 2.0×	12	56
Anne Escande France	3	32 1.1×	11 0.7×	23 1.6×	6 0.7×	23 2.9×	5	44
Yuwa Ando Japan	5	38 1.3×	14 0.9×	16 1.1×	10 1.1×	5 0.6×	5	68
Annalisa lo Conte Netherlands	3	41 1.4×	7 0.4×	13 0.9×	11 1.2×	26 3.3×	3	44
Andreas Beckmann Germany	4	18 0.6×	9 0.6×	11 0.8×	9 1.0×	8 1.0×	7	47
Aparna Parikh United States	4	17 0.6×	7 0.4×	13 0.9×	8 0.9×	10 1.3×	15	37
Shazia Hafiz United Kingdom	3	14 0.5×	16 1.0×	7 0.5×	3 0.3×	13 1.6×	6	44
Marcos André Costa Brazil	3	16 0.5×	7 0.4×	10 0.7×	4 0.4×	6 0.8×	3	17
Lionel Jouffret France	3	23 0.8×	5 0.3×	5 0.4×	10 1.1×	12 1.5×	4	24

Countries citing papers authored by Leif Klint

Since Specialization

Citations

This map shows the geographic impact of Leif Klint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Klint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Klint more than expected).

Fields of papers citing papers by Leif Klint

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Klint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Klint. The network helps show where Leif Klint may publish in the future.

Co-authorship network of co-authors of Leif Klint

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Klint. A scholar is included among the top collaborators of Leif Klint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Klint. Leif Klint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kovács, Anikó, Leif Klint, Barbro Linderholm, & Toshima Z. Parris. (2025). Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence. Breast Cancer Research and Treatment. 213(3). 397–408. 1 indexed citations

2.

Larsson, Karolina, et al.. (2024). Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer – efficacy, tolerability and quality of life results from the phase II METRO trial. The Breast. 78. 103795–103795.

3.

Labori, Knut Jørgen, Svein Olav Bratlie, Christina Biörserud, et al.. (2023). Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1).. Journal of Clinical Oncology. 41(17_suppl). LBA4005–LBA4005. 28 indexed citations

4.

Klint, Leif, Anikó Kovács, Elisabeth Werner Rönnerman, & Barbro Linderholm. (2021). Real world data on adjuvant treatment of older HER2-positive breast cancer patients – A single institution experience through 8 years. Cancer Treatment and Research Communications. 28. 100430–100430. 2 indexed citations

5.

Klint, Leif, et al.. (2012). Abstract P6-12-01: Adjuvant treatment in breast cancer patients aged 70 years or older during three years. A systematic review of patients charts.. Cancer Research. 72(24_Supplement). P6–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact